Гематология
1411 статей · 38 журналов
Журналы подкатегории (38)
- Annals of Thoracic Surgery Short Reports · Elsevier (89)
- Blood Advances · Elsevier (89)
- Journal of Thrombosis and Haemostasis · Elsevier (85)
- Research and Practice in Thrombosis and Haemostasis · Elsevier (80)
- Thrombosis Research · Elsevier (80)
- British Journal of Haematology · Wiley (75)
- European Journal of Haematology · Wiley (74)
- Clinical Lymphoma, Myeloma & Leukemia · Elsevier (71)
- Transfusion and Apheresis Science · Elsevier (69)
- Radiotherapy & Oncology · Elsevier (66)
- Blood · Elsevier (65)
- Vox Sanguinis · Wiley (65)
- Annals of Oncology · Elsevier (62)
- American Journal of Hematology · Wiley (58)
- Haemophilia · Wiley (58)
- Hematology/Oncology Clinics of North America · Elsevier (50)
- Transfusion · Wiley (49)
- Transfusion Medicine Reviews · Elsevier (39)
- Seminars in Hematology · Elsevier (37)
- The Lancet Haematology · Elsevier (28)
- Seminars in Oncology · Elsevier (27)
- Experimental Hematology · Elsevier (21)
- HemaSphere · Wiley (17)
- Thrombosis Update · Elsevier (14)
- Transfusion Medicine · Wiley (13)
- Journal of Clinical Apheresis · Wiley (12)
- Blood Cancer Journal · Springer Nature (7)
- Leukemia · Springer Nature (7)
- Ca-A Cancer Journal for Clinicians · Wiley (4)
- Annals of Hematology · Springer Nature (0)
- Blood Research · Springer Nature (0)
- Experimental Hematology & Oncology · Springer Nature (0)
- Indian Journal of Hematology and Blood Transfusion · Springer Nature (0)
- International Journal of Clinical Oncology · Springer Nature (0)
- International Journal of Hematology · Springer Nature (0)
- Medical Oncology · Springer Nature (0)
- Thrombosis Journal · Springer Nature (0)
- memo - Magazine of European Medical Oncology · Springer Nature (0)
-
BCMA Targeted Therapies and Their Impact on Outcomes in Relapsed or Refractory Multiple Myeloma: Results From the French EMMY Cohort
ABSTRACT Objectives B‐cell maturation antigen (BCMA)‐targeted therapies have recently transformed the management of relapsed or refractory multiple myeloma (RRMM). This study aimed to evaluate their implementation and real‐world impact...
- Comment on Sakthivel Et al., “Central Venous Access Device Complications in Children With Leukemia: A Systematic Review and Meta‐Analysis”
-
Castleman Disease: Unraveling Diagnostic Challenges Through Clinical and Pathologic Perspectives
ABSTRACT Castleman disease (CD) comprises a heterogenous group of rare nonmalignant lymphoproliferative disorders. CD is classified as unicentric (UCD) and multicentric CD (MCD) depending on the number of lymph node region involvement....
-
Posaconazole Prophylaxis for the Prevention of Invasive Fungal Infections in Patients With Hematologic Malignancies: A Systematic Review and Meta‐Analysis
ABSTRACT Background Invasive fungal infections (IFIs) pose a life‐threatening risk to patients with hematologic malignancies undergoing intensive chemotherapy. Although posaconazole is widely used as a standard prophylactic agent, a...
-
Ferritin Normalization Is Not Disease Control in HFE‐Related Hemochromatosis: Residual Risk, Transferrin Saturation, and the Hepcidin–Ferroportin Axis
ABSTRACT HFE ‐related hemochromatosis is conventionally managed as a disorder of iron excess, with therapeutic phlebotomy as effective, inexpensive, first‐line therapy. Ferritin normalization, however, may not fully capture clinical...
- From Association to Prevention: Validating SGLT2 Inhibition Across the MGUS‐Myeloma Continuum
-
TP53‐Altered Aggressive Large B‐Cell Lymphoma (LBCL) Outcomes by Treatment Modality: A Multicenter Cohort From 14 US Centers
ABSTRACT Advances in the treatment of large B‐cell lymphoma (LBCL) have expanded therapeutic options beyond conventional chemoimmunotherapy to include cellular and targeted therapies. There is growing interest in identifying subsets of...
-
Post‐Hoc Long‐Read Sequencing Links Leukemic Mutation Status to Single‐Cell Transcriptomes
ABSTRACT Single‐cell RNA‐sequencing‐based characterization of cells that belong to the neoplastic clone is a major challenge in hematologic neoplasms, where malignant and normal cells coexist. Confident molecular profiling requires...
-
Toxicity‐Related Treatment Cessation in Newly Diagnosed Multiple Myeloma—Risk Factors and Survival: An Analysis From the APAC and ANZ Myeloma and Related Diseases Registry
ABSTRACT Background Toxicity‐related treatment cessation (TTC) limits optimal outcomes in newly diagnosed multiple myeloma (NDMM), but its determinants and prognostic relevance remain unclear. Methods A total of 3095 NDMM patients were...
-
Impact of Vincristine Dose Reduction on Outcomes of Patients With Advanced‐Stage Diffuse Large B‐Cell Lymphoma Treated With R‐CHOP
ABSTRACT Introduction Vincristine dose reduction during R‐CHOP treatment of diffuse large B‐cell lymphoma (DLBCL) is frequently required due to vincristine‐induced polyneuropathy (VIPN). Previous studies suggested an association between...
- From Prediction to Prevention: Validating the CLLAF Score Across Care Settings
- Serial VAF Kinetics Reveal Dynamic Clonal Evolution Associated With Progression in Clonal Cytopenia of Undetermined Significance
- Transplantation Strategies in Treatment of Primary Plasma Cell Leukemia in Germany—A Multi‐Center Analysis
- Translational Insights From the Molecular Landscape to Precision Therapy in Peripheral T‐Cell Lymphoma: Integrating Multi‐Omics and Artificial Intelligence
- Clinical Outcomes of Younger Adults With Philadelphia‐Negative Acute Lymphoblastic Leukemia, Treated With A Pediatric‐Like Regimen Based on the GIMEMA LAL1308 Protocol. A Campus ALL Study
- Prevalence and Disability of Peripheral Neuropathy in Patients With Waldenström's Macroglobulinemia
- Treatment Patterns, Outcomes and Survival Trends in T‐Cell Prolymphocytic Leukemia: A Nationwide Population‐Based Study in the Netherlands
- A Reassessment of the Validity of the Routine Lymph2Cx Assay for the Cell‐of‐Origin Assignment of Diffuse Large B‐Cell Lymphoma
- High Prevalence of the JAK2V617F Mutation in Patients With Acute Coronary Syndrome
- Oral factor Xa inhibitor-related major bleeding events in the Netherlands: a population-based study
- Sickle Cell Disease: Expanding the Frontiers of Pathophysiology and Therapeutics
- Pain in SCD—Many mechanisms and mysteries
- The many facets of cardiopulmonary complications in sickle cell disease
- More disease-modifying therapies for sickle cell disease: Are small molecules and drug repurposing the way forward?
- Abnormal lipid profiles are associated with markers of impaired fibrinolysis in patients with cirrhosis
- Association of the sarcopenia index based on the serum creatinine to cystatin C ratio and genetic risk with venous thromboembolism: a population-based cohort study
- A screening assay for type 2B von Willebrand factor variants using an enzyme-linked immunosorbent assay based on recombinant wild-type glycoprotein Ib and ristocetin
- Clinical significance of symptomatic and incidental venous thromboembolism in patients with cancer treated with apixaban
- Long-term outcomes of antithrombotic treatment for retinal vein occlusion
- Suspicion-based screening for occult malignancy in lower-extremity venous thrombosis: a real-world cohort study